The reliance of cancer cells on glutamine metabolism has been observed in numerous tumorigenic contexts and is enhanced by the expression of proto-oncogenes c-myc and E2F, which control the expression of genes involved in glutamine metabolism (3, –, 5). The gene discussed is MYC; the disease is cancer.